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Abstract
We present the case of an eighteen-year-old Caucasian white boy who was diagnosed with
xeroderma pigmentosum type A at age 5 and who experienced over the past year disseminated
small plaque psoriasis confirmed with skin punch biopsy. The psoriatic lesions were successfully
treated with multipotent topical corticosteroids and systemic retinoids. To our knowledge, the
association between psoriasis and xeroderma pigmentosum has not been previously reported and
may be regarded as unlikely when considering the pathogenesis of both diseases.
Background
Xeroderma pigmentosum (XP) is a rare autosomal reces-
sive disorder characterized by a defect of DNA-repair
occurring during UV-induced damage. The disease is quite
complex and different subsets of abnormalities in the
DNA-repair system may be present during the course of
the disease. Thus, patients with XP have a decreased cuta-
neous immune surveillance which results in an increased
risk of UV-induced skin tumours at an early age. Basal cell
carcinoma (BCC), squamous cell carcinoma (SCC),
actinic keratoses, atypical moles and malignant
melanoma, all associated with severe photoaging are
commonly seen in such patients. The prognosis of XP is
based on early diagnosis as to permit strict UV avoidance
and early detection and treatment of skin tumours, espe-
cially in photo-exposed areas.
Case presentation
We present the case of an eighteen-year-old white Cauca-
sian boy who was diagnosed with XP type A at age 5.
Other clinical signs include photophobia, keratitis and
loss of eyelashes. Despite rigorous monitoring and photo-
protection, the patient developed over 100 facial skin can-
cers (mainly BCC and SCC) treated with cryotherapy and
surgery. Surprisingly, the patient experienced over the past
year disseminated small plaque psoriasis (Fig. 1) con-
firmed with skin punch biopsy. S100 staining showed
reduced density of Langerhans cells in healthy skin (Fig.
2), as previously reported in XP group A [1]. The psoriatic
lesions were successfully treated with multipotent topical
corticosteroids and systemic retinoids.
Discussion
To our knowledge, the association between psoriasis and
XP has not been previously reported and may be regarded
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as unlikely when considering the pathogenesis of both
diseases.
XP patients exhibit Langerhans cell depletion, intensified
impairment of natural killer (NK) cell function and
enhanced UV-immunosuppression, possibly mediated
through increased prostaglandin E2 production [1-4]. By
opposition, psoriatic plaques are characterized by
immune activation, with NK cell activation and decreased
cyclo-oxygenase activity [5,6].
In addition, in XP, unrestricted cellular proliferation is
associated with inactivation of members of the iNK4a/Arf
locus, such as p14 and p16 [7]. By opposition, in psoria-
sis, members of the iNK4a/Arf locus are overexpressed,
which may contribute to the senescent switch and resist-
ance of psoriatic plaques to cellular transformation
despite altered differentiation, angiogenesis, increased tel-
omerase activity, proliferative changes and apoptosis
resistance characterising psoriatic skin [8,9].
Further data are required to determine why and how those
apparently antinomic diseases can coexist.
Abbreviations
BCC: Basal cell carcinoma; DNA: desoxy ribonucleic acid;
iNK: invariant natural killer; NK: natural killer; SCC: squa-
mous cell carcinoma; UV: ultraviolet; XP: xeroderma pig-
mentosum.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
KE, TS, MH examined the patient. KE and TS were the
major contributors in writing the manuscript. DM first
seen the patient and helped to the redaction of the manu-
script. MH and MC treated the patient and MH performed
the histological examination for the skin biopsy. All
authors read and approved the final manuscript.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
References
1. Jimbo T, Ichihashi M, Mishima Y, Fujiwara Y: Role of excision repair
in UVB-induced depletion and recovery of human epidermal
Langerhans cells.  Arch Dermatol 1992, 128:61-7.
2. Horio T, Miyauchi-Hashimoto H, Kuwamoto K, Horiki S, Okamoto
H, Tanaka K: Photobiologic and photoimmunologic character-
istics of XPA gene-deficient mice.  J Investig Dermatol Symp Proc
2001, 6:58-63.
3. Kolgen W, van Steeg H, Horst GT van der, Hoeijmakers JH, van Vlo-
ten WA, de Gruijl FR, Garssen J: Association of transcription-
coupled repair but not global genome repair with ultravio-
Association of small erythematous scaly plaques with multi- ple areas of hyperpigmentation resembling freckles on the  patient's back Figure 1
Association of small erythematous scaly plaques with multi-
ple areas of hyperpigmentation resembling freckles on the 
patient's back.
S100 staining showing reduced density of Langerhans cells in  healthy skin Figure 2
S100 staining showing reduced density of Langerhans cells in 
healthy skin.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Cases Journal 2008, 1:74 http://www.casesjournal.com/content/1/1/74
Page 3 of 3
(page number not for citation purposes)
let-B-induced Langerhans cell depletion and local immuno-
suppression.  J Invest Dermatol 2003, 121:751-6.
4. Ottaviani C, Nasorri F, Bedini C, de Pita O, Girolomoni G, Cavani A:
CD56brightCD16(-) NK cells accumulate in psoriatic skin in
response to CXCL10 and CCL5 and exacerbate skin inflam-
mation.  Eur J Immunol 2006, 36:118-28.
5. Kanda N, Mitsui H, Watanabe S: Prostaglandin E(2) suppresses
CCL27 production through EP2 and EP3 receptors in human
keratinocytes.  J Allergy Clin Immunol 2004, 114:1403-9.
6. Remy W, Sigl I, Leipold B: Prostaglandin E2 gel improvement of
psoriatic lesions.  Int J Dermatol 1986, 25:266-8.
7. Soufir N, Daya-Grosjean L, de La Salmoniere P, Moles JP, Dubertret
L, Sarasin A, Basset-Seguin N: Association between INK4a-ARF
and p53 mutations in skin carcinomas of xeroderma pigmen-
tosum patients.  J Natl Cancer Inst 2000, 92:1841-7.
8. Chaturvedi V, Cesnjaj M, Bacon P, Panella J, Choubey D, Diaz MO,
Nickoloff BJ: Role of INK4a/Arf locus-encoded senescent
checkpoints activated in normal and psoriatic keratinocytes.
Am J Pathol 2003, 162:161-70.
9. Nickoloff BJ: Creation of psoriatic plaques: the ultimate tumor
suppressor pathway. A new model for an ancient T-cell-
mediated skin disease. Viewpoint.  J Cutan Pathol 2001, 28:57-64.